In cervical cancer patients, we found CSCC cohorts obtained higher TMB score, MSI score and common inhibitory checkpoints expression (e.g., PDCD1, CD274, BTLA, CTLA4, TIGIT, etc.), accompanied by more abundant immunocytes infiltration. This evidence concerns the gene TIGIT and cervical carcinoma.